Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

112 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Guidelines for the management of chronic hepatitis C in patients infected after substance use.
Robaeys G, Buntinx F, Bottieau E, Bourgeois S, Brenard R, Colle I, De Bie J, Matheï C, Mulkay JP, Van Damme P, Van Ranst M, Verrando R, Michielsen P, Bourgeois N, Brenard R, de Galocsy Ch, Delwaide J, Henrion J, Horsmans Y, Michielsen P, Reynaert H, Robaeys G, Sprengers D; Steering Committee of the Belgian Association for the Study of the Liver (BASL). Robaeys G, et al. Acta Gastroenterol Belg. 2005 Jan-Mar;68(1):38-45. Acta Gastroenterol Belg. 2005. PMID: 15832586 Review. No abstract available.
Risk factors for hepatitis C: past, present and future.
Delwaide J, Bourgeois N, Colle I, Robaeys G. Delwaide J, et al. Among authors: robaeys g. Acta Gastroenterol Belg. 2002 Apr-Jun;65(2):87-9. Acta Gastroenterol Belg. 2002. PMID: 12148445 Review.
Hepatitis C: screening, treatment and prevention practical guidelines.
Michielsen P, Brenard R, Bourgeois N, De Galocsy Ch, Delwaide J, Henrion J, Horsmans Y, Nevens F, Reynaert H, Robaeys G, Sprengers D, Van Vlierberghe H; Steering Committee Belgian Association for the Study of the Liver. Michielsen P, et al. Among authors: robaeys g. Acta Gastroenterol Belg. 2003 Jan-Mar;66(1):15-9. Acta Gastroenterol Belg. 2003. PMID: 12812144 No abstract available.
Daily induction combination treatment with alpha 2b interferon and ribavirin or standard combination treatment in naive chronic hepatitis C patients. A multicentre randomized controlled trial.
Van Vlierberghe H, Leroux-Roels G, Adler M, Bourgeois N, Nevens F, Horsmans Y, Brouwer J, Colle I, Delwaide J, Brenard R, Bastens B, Henrion J, de Vries RA, de Galocsy C, Michielsen P, Robaeys G, Bruckers L. Van Vlierberghe H, et al. Among authors: robaeys g. J Viral Hepat. 2003 Nov;10(6):460-6. doi: 10.1046/j.1365-2893.2003.00466.x. J Viral Hepat. 2003. PMID: 14633181 Clinical Trial.
Treatment of acute hepatitis C with interferon alpha-2b: early initiation of treatment is the most effective predictive factor of sustained viral response.
Delwaide J, Bourgeois N, Gérard C, De Maeght S, Mokaddem F, Wain E, Bastens B, Fevery J, Géhénot M, Le Moine O, Martinet JP, Robaeys G, Servais B, Van Gossum M, Van Vlierberghe H; Belgian Association for the Study of the Liver (BASL). Delwaide J, et al. Among authors: robaeys g. Aliment Pharmacol Ther. 2004 Jul 1;20(1):15-22. doi: 10.1111/j.1365-2036.2004.02023.x. Aliment Pharmacol Ther. 2004. PMID: 15225166 Clinical Trial.
112 results